We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $101M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+5.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$94.2M
AUM Growth
+$4.34M
Cap. Flow
+$904K
Cap. Flow %
0.96%
Top 10 Hldgs %
54.61%
Holding
37
New
4
Increased
14
Reduced
15
Closed
1

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$4.22M
2
APO icon
Apollo Global Management
APO
+$2.32M
3
AER icon
AerCap
AER
+$1.72M
4
FTV icon
Fortive
FTV
+$1.69M
5
CRH icon
CRH
CRH
+$1.67M

Top Sells

Rank Stock Value
1
ICUI icon
ICU Medical
ICUI
+$5.99M
2
ACA icon
Arcosa
ACA
+$3.23M
3
CBZ icon
CBIZ
CBZ
+$3.09M
4
CNMD icon
CONMED
CNMD
+$1.39M
5
LAB icon
Standard BioTools
LAB
+$1.14M

Sector Composition

Rank Sector Weight
1 Healthcare 35.27%
2 Industrials 25.84%
3 Financials 19.28%
4 Technology 7.33%
5 Materials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACA icon
26
Arcosa
ACA
$7.11B
$1.04M 1.1%
9,750
-32,000
-77% -$3.23M
LPX icon
27
Louisiana-Pacific
LPX
$5.14B
$1.01M 1.07%
+12,500
New +$1.06M
NCNO icon
28
nCino
NCNO
$2.06B
$962K 1.02%
+37,500
New +$952K
WWD icon
29
Woodward
WWD
$23B
$756K 0.8%
2,500
TDW icon
30
Tidewater
TDW
$3.63B
$631K 0.67%
12,500
+5,000
+67% +$264K
LAB icon
31
Standard BioTools
LAB
$342M
$608K 0.65%
475,000
-850,000
-64% -$1.14M
BXMT icon
32
Blackstone Mortgage Trust
BXMT
$2.77B
$526K 0.56%
27,500
-60,000
-69% -$1.14M
SXT icon
33
Sensient Technologies
SXT
$5.22B
$470K 0.5%
5,000
-5,000
-50% -$472K
CNMD icon
34
CONMED
CNMD
$1.3B
$386K 0.41%
9,500
-32,000
-77% -$1.39M
PBH icon
35
Prestige Consumer Healthcare
PBH
$2.47B
$308K 0.33%
5,000
-7,500
-60% -$459K
CNNE icon
36
Cannae Holdings
CNNE
$653M
$197K 0.21%
12,500
-65,000
-84% -$1.11M
PRM icon
37
Perimeter Solutions
PRM
$5.66B
-27,500
Closed -$616K

Similar funds

Pacific Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Pacific Capital Partners held 37 positions worth $94.2M, up 4.8% from $89.8M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Pacific Capital Partners's Q4 2025 filing shows 4 new, 14 increased, 15 reduced and 1 closed positions. Its largest new stake was Apollo Global Management: 17,500 shares worth $2.53M. The largest sale was ICU Medical, an estimated $5.99M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 42% a quarter earlier, followed by Industrials and Financials.

  • Pacific Capital Partners's largest Q4 2025 buy was Apollo Global Management: 17,500 shares worth $2.53M.
  • Pacific Capital Partners added most to Union Pacific in Q4 2025, an estimated $4.22M increase.
  • Pacific Capital Partners's biggest Q4 2025 reduction was ICU Medical, cutting an estimated $5.99M.
  • Pacific Capital Partners fully exited Perimeter Solutions in Q4 2025, selling an estimated $616K.
  • Pacific Capital Partners's ten largest holdings make up 55% of its $94.2M portfolio in Q4 2025.
  • Pacific Capital Partners opened 4 new positions and closed 1 in Q4 2025.
  • Pacific Capital Partners's portfolio value rose 4.8% quarter-over-quarter to $94.2M.

Based on Pacific Capital Partners's 13F filing for Q4 2025, filed 15 Jan 2026.